Treatment-free Remission in Chronic Myeloid Leukaemia: A Critical Appraisal of the Evidence, Persistent Uncertainties and Research Priorities
Nilkamal Kumar & Nishant Sinha · International Research Journal of Oncology · 2026
Chronic myeloid leukaemia (CML) has been transformed by BCR::ABL1 tyrosine kinase inhibitors (TKIs), and for many patients life expectancy now approaches that of the general population. Against this background, treatment-free remission (TFR), defined as the maintenance of molecul...
Open access
Research Article
10.9734/irjo/2026/v9i2228